Veterinary Medicines

EURICAN DAPPI-L, κόνις και διαλύτης για ενέσιμο εναιώρημα για σκύλους

Authorised
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Download as PDF

Product identification

Medicine name:
EURICAN DAPPI-L, κόνις και διαλύτης για ενέσιμο εναιώρημα για σκύλους
Active substance:
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
  • Canine parvovirus, strain CAG2, Live
  • Canine adenovirus 2, strain DK13, Live
  • Canine distemper virus, strain BA5, Live
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serovar Canicola, Inactivated
  • Canine parainfluenza virus, strain CGF 2004/75, Live
    50.12
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine parvovirus, strain CAG2, Live
    79.43
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine adenovirus 2, strain DK13, Live
    316.22
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Canine distemper virus, strain BA5, Live
    10000.00
    50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Powder and solvent for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 38630/27-04-2017/K-0225001
Date of authorisation status change: